Clinical Trial Update: Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842) [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial safety update reports on the safety of Org 34517 900 mg in patients who had previously received Org 34517 in an earlier study (Study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Psychotic Disorders

Drugs mentioned

• ORG 34517

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Depressive Disorders, Psychotic Disorders | Phase 2 | Status: COMPLETED